Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1472-1476

  Inoue, Tomio ^b   Kim, E Edmund ^a   Wong, Franklin C L ^b   Yang, David J ^b   Bassa, Pedro ^b   Wong, Wai Hoi ^b   Korkmaz, Meliha ^b   Tansey, Wayne ^b   Hicks, Keri ^b   Podoloff, Donald A ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

carbon 11 methionine; fluorine 18 FDG; PET; recurrent tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMAL RESIDUAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION;

ADULT; AGED; BONE NEOPLASMS; BREAST NEOPLASMS; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; METHIONINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 10144231440     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Glazer HS, Lee JKT, Levitt RG, et al. Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 1985;156:721-726.
2. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
3. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36:788-793.
4. Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. J Nucl Med 1993;34:1886-1891.
5. Lindholm P, Leskinen-Kallio S, Minn H, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck caner. J Nucl Med 1993;34: 1711-1716.
6. Leskinen-Kallio S, Ruotsalainen U, Någren K, Teräs M, Joensuu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991;32:1211-1218.
7. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
8. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993;189:847-850.
9. Wong WH, Uribe J, Hicks K, Hu G. An analog decoding BGO block detector using circular PMT. IEEE Nucl Sci Trans 1995;42:(1095).
10. Minn H, Clavo AC, Gréman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995;36:252-258.
11. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-492.
12. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994;35:104-112.
13. Griffeth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft-tissue masses with fluorine-18-fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-194.
14. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992;33:333-339.
15. Fujiwara T, Matsukawa T, Kubota K, et al. Relationship between histologie type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography. J Nucl Med 1989;30:33-37.
16. Leskin-Kallio S, Någren K, Lehikoinen P, Ruotsalainen U. Teräs M, Joensuu H. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992;33:691-695.
17. 3H]thymidine, and gallium-67. J Nucl Med 1991;32:2118-2123.
18. Slosmon DO, Pittet N, Donath A, Polla BS. Fluorodeoxyglucose cell incorporation as an index of cell proliferation: evaluation of accuracy in cell culture. Eur J Nucl Med 1993;20:1084-1088.
19. Lapela M, Leskinen-Kallio S, Varpula M, et al. Imaging of uterine carcinoma by carbon-11-methionine and PET. J Nucl Med 1994;35:1618-1623.
20. Langer K-J, Braun U, Kops ER, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993;34:355-359.